|
1
|
- A Neuroimaging Review of Common Myelin Disorders
|
|
2
|
- A Neuroimaging Review of Common Myelin Disorders
|
|
3
|
- The term leukoencephalopathy is broad and encompasses a heterogeneous
group of diseases that primarily affect the white matter of the CNS.
- The disease entities include both primary myelin disorders, axonal/neuronal
degeneration and inflammatory disorders.
|
|
4
|
- Leukoencephalopathies are commonly divided into two categories:
- Dysmyelinating Diseases
- Also known as leukodystrophies, these disorders result from an
inherited defect usually in an enzyme pathway or organelle function,
which leads to abnormal formation, destruction, or turnover of myelin.
- Demyelinating Diseases
- A group of acquired disorders which result in abnormal destruction of
intrinsically normal myelin and/or axons.
|
|
5
|
- MR imaging has emerged as the primary modality for detecting and
characterizing white matter disorders.
- MR findings are often nonspecific. We present a systematic review of the
most common features of leukoencephalopathies to help the reader better
organize and evaluate these complicated disorders.
- Diagnosis is ultimately made from a combination of physical,
biochemical, and imaging findings.
- We will begin with a review of the current classification of the
leukoencephalopathies.
|
|
6
|
- Disorders of white matter are divided into heritable enzyme/organelle
defects and acquired processes which destroy normal myelin. These
categories are further subdivided into:
|
|
7
|
- Lysosomal
- Metachromatic Leukodystophy (MLD)
- Krabbe Disease
- Mucopolysaccharidosis
- Gangliosidoses GM2
- Peroxisomal
- X-linked Adrenoleukodystrophy
- Zellweger syndrome
- Mitochondrial
- MELAS
- Leigh Disease
- Kearns-Sayre Syndrome
- Glutaric Aciduria
- Alpers Disease
- Non-Specific Mitochondrial encephalopathy
|
|
8
|
- Non-infectious/ Non-inflammatory
- Multiple Sclerosis
- Neuromyelitis Optica
- (Devic disease)
- Infectious/Inflammatory
- Acute Disseminated encephalomyelitis (ADEM)
- Subacute Sclerosing Panencephalitis (SSPE)
- Progressive Multifocal Leukoencephalopathy
- (PML)
- Subacute HIV infection
- Viral Encephalitides
|
|
9
|
|
|
10
|
|
|
11
|
- Inheritance pattern:
- Enzyme defect:
- Lysosomal Arylsulfatase A
- This enzyme is necessary for the normal metabolism of sulfatides, a
normal constituent of myelin
- MLD is diagnosed biochemically on the basis of an abnormally low level
of arylsulfatase A in peripheral blood leukocytes.
|
|
12
|
- Clinical:
- 3 forms:
- late infantile – most common; manifests between 12 and 18 months
- juvenile
- adult
- Characterized by motor signs of peripheral neuropathy including muscle
hypotonia, deterioration in intellect, speech and coordination. Vision
is impaired due to optic nerve atrophy.
- Eventually the child becomes blind and completely tetraplegic in a
decerebrate state without purposeful movements.
- Death occurs 6 months to 4 years after symptom onset.
|
|
13
|
- MR imaging features:
- ↑ T2 signal reported earliest in the corpus callosum, the
internal capsules and corticospinal tracts are frequently involved (see
figs c & d)
- T2 high signal is seen more or less symmetrically in the
periventricular white matter, in a highly confluent pattern (see figs a
& b) with characteristic sparing of the subcortical U-fibers
- A striped or tigroid appearance of the periventricular white matter is
seen (fig b) with central low signal indicating sparing of the
perivascular white matter
- Cerebellar white matter may also be involved
- Typically no enhancement
|
|
14
|
- Inheritance pattern:
- Enzyme defect:
- Lysosomal Galactocerebroside ß-galactosidase
- This enzyme is necessary in the first step of metabolism of
cerebroside, a normal constituent of myelin – cerebrosides accumulate
in the lysosomes within white matter, creating the characteristic
globoid cells.
|
|
15
|
- Clinical:
- 4 recognized forms:
- Infantile – most common; manifests between 1 and 6 months
- Late infantile
- Juvenile
- Adult
- Initially presents with hyperirritability and periods of fever without
other signs of infection.
- Muscle tone increases with subsequent rapid and severe motor and mental
deterioration with constant opisthotonus and hypertonic flexion of the
arms and extension of the legs.
- The disease rapidly progresses with death ensuing between 5 months and
3 years of age.
|
|
16
|
- MR Imaging features
- ↑T2 seen in the periventricular white matter with sparing of the
subcortical
U-fibers
- A radiating striped or tigroid appearance is often observed in the
white matter, correlating pathologically with perivascular deposits of
globoid cells
(fig b)
- Posterior limb internal capsule, cerebellar white matter and pyramidal
tracts in the brainstem are involved (arrow fig a)
- With progression of disease, the subcortical white matter becomes
involved with generalized atrophy
- Subtle enhancement is variably seen, usually at the junction between
normal and abnormal white matter
|
|
17
|
- Mucopolysaccharidoses constitute a group of disorders caused by
deficiencies of lysosomal enzymes responsible for metabolism of
mucopolysaccharides (glycosaminoglycans).
- Demonstrates ↑ concentration of glycosaminoglycans in the brain
and leptomeniges.
- There are a total of six subdivisions to date which share several
clinical features and are subdivided by genetic and biochemical
differences.
|
|
18
|
- Inheritance pattern:
- Enzyme defect
- Autosomal recessive
- Deficiency in α-L-ironidase
- Clinical:
- 3 subtypes: Hurler, Hurler–Scheie, Scheie (mild)
- There is considerable clinical variability
- Normal intelligence to progressive mental retardation, macrocephaly,
skeletal abnormalities, hepatosplenomegaly, cardiovascular involvement
- Patients with Hurler’s demonstrate progressive physical and neurologic
deterioration, rarely surviving beyond 16 years of age, while patients
with Scheie syndrome may be nearly normal
|
|
19
|
- MR imaging features:
- Cystic foci in corpus callosum, basal ganglia and cerebral WM
representing enlarged perivascular CSF spaces filled with CSF or
mucopolysacchride (arrow fig a)
- Multifocal ↑ T2 signal in the cerebral WM representing gliosis
- Ventricular enlargement 2° to hydrocephalus
|
|
20
|
- Inheritance pattern:
- Enzyme defect:
- Deficiency in L-sulfoiduronate sulfatase
- Clinical:
- Visual disturbances, progressive
deafness, hepatosplenomegaly, cutaneous manifestations
|
|
21
|
- MR imaging
- Scattered ↑ T2 & flair signal predominantly through out the
white matter representing gliosis
- Small punched out cystic lesions in subcortical WM representing
enlarged perivascular spaces filled with CSF or mucopolysacchride. (figs
a & b)
- Ventricular enlargement 2° to hydrocephalus
|
|
22
|
- Inherited disorder of GM2 ganglioside metabolism resulting in neuronal
loss and WM degeneration
- 3 Major subtypes
- Type AB – Infantile form
- Type B – Tay-Sachs disease
- Type O – Sandhoff disease
- Inheritance pattern:
- Enzyme defect
- Deficiency in hexosaminidase with abnormal accumulation of GM2
ganglioside in cytoplasm of neurons resulting in neuronal loss WM
degenration
- Dx: assaying hexosaminidase A & B in serum, leukocyte or cultured
skin fibroblasts.
|
|
23
|
- Clinical
- Similar clinical presentation for Tay-Sachs and Sandhoff
- Psychomotor retardation and hypotonia, neurologic deterioration in the
1st year of life
- Progressive motor weakness, spasticity, dystonia, choreaform movements,
ataxia, blindness, macrocephaly and seizures
- Patient becomes bedridden and demented 3 – 10 years
|
|
24
|
- Tay-Sachs disease
- MR imaging
- ↑ T2 thalami, caudate nucleus, globus pallidus and putamen
- ↑ T1 in globus pallidus, putamen and thalami
- Diffuse progression of ↑ T2 in the WM
- Sandhoff disease
- MR imaging
- Similar findings to Tay-Sachs with less severity
|
|
25
|
|
|
26
|
- Inheritance pattern:
- Enzyme defect:
- Genetic defect terminal segment of long arm of X chromosome
- Deficiency of acyl-CoA synthetase
- Dx by chromosomal assay of plasma, RBC’s or cultured fibroblasts
|
|
27
|
- Clinical:
- Effects white matter in CNS, adrenal cortex and testes
- Two major forms
- Childhood cerebral form
- Between 5 and 12 yrs
- Initial presentation of learning difficulties, impaired visual
acuity, hearing difficulties, gait disturbance
- Abnormal skin pigmentation (bronzing), typically predates neurologic
abnormalities 2° to adrenal insufficiency
- Adrenomyeloneuropathy
- Presents in young adults
- Incontinence, progressive paraparesis, progressive cerebellar
dysfunction
|
|
28
|
- MR features
- Marked ↑ T2 and ↓ T1 white matter signal abnormalities
- Posterior predominance, splenium of corpus callosum (80%)
- Frontal white matter, genu of corpus callosum (15%)
- Typically spares the U-fibers
- Enhancement of inflammatory leading edge of demyelination (correlates
with worsening clinical status)
|
|
29
|
|
|
30
|
- Etiology:
- Possible deletions of mitochondrial DNA
- Theory – mitochondrial vasculopathy of small arteries resulting
in areas of infarct
- Clinical:
- Episodes of throbbing headache, nausea, vomiting, permanent or
reversible stroke-like events
- Presentation most commonly 2nd decade, however may present
at any age
- ↑ serum and CSF lactate
|
|
31
|
- MR features:
- Variable distribution of ↑T2 and flair signal abnormalities that
do not follow vascular distribution.
- Cortex is more severely affected than the underlying WM
- Cortex enhances after contrast
- ADC values controversial, studies showing ↑, normal or ↓
values.
|
|
32
|
- Inheritance pattern:
- Enzyme defect:
- Deficiency of glutaryl-CoA dehydrogenase
- Clinical:
- Age of presentation by 12 months
- Excessive excretion of glutaric acid, glutaconic acid and
3-hydroxy-glutaric acid in the urine
- Macrocephaly, acute encephalopathy, gradual hypotonia, progressive
dystonia, choreoathetosis, tetraplegia
|
|
33
|
- MR features
- Large CSF spaces over convexities in frontoparietal and frontotemporal
regions
- Prone to developing subdural hemorrhage from stretched bridging veins
(ddx. nonaccidental trauma)
(fig c)
- Wide sylvian fissures (fig a) due to lack of operculeriztion of the
frontal and temporal lobes
- ↑ T2 in putamen, globus pallidus, caudate head, dentate nucleus,
substantia nigra
- Delayed myelination affecting the frontal and occipital PVWM
|
|
34
|
- Subacute necrotizing encephalopathy
- Neurodegenerative disorder
- Inheritance pattern:
- Autosomal recessive (most cases) and X-linked
- Etiology
- Inborn error of energy metabolism
- Defective terminal oxidative metabolism divided into 4 main groups
- Pyruvate dehydrogenase deficiency complex
- Complex I deficiency
- Complex II deficiency
- Complex IV - Cytochrome oxidase deficiency
- Complex V – defects in subunit 6 of ATP synthetase
|
|
35
|
- Clinical:
- Variable clinical and pathologic manifestations
- Multisystem disorder dominated by signs of CNS dysfunction
- Pathologic abnormalities – microcystic cavitation, vascular
proliferation, neuronal loss, demyelination in midbrain, basal ganglia
and dentate nuclei and occasional white matter involvement
- Present typically toward the end of 1st yr of life in
infants
- Hypotonia, psychomotor deterioration, ataxia, ophthalmoplegia, ptosis,
dystonia, cranial nerve palsies
- Causes of death – neurogenic disturbances of respiration, convulsions,
coma, hyperpyrexia, cardiac
|
|
36
|
|
|
37
|
- Inheritance pattern:
- Enzyme defect:
- Biochemical studies are diagnostic
- Deficiency in aspartoacylase resulting in ↑ N-acetyl aspartic
acid in urine and plasma
- Accumulation of N-acetylaspartate in oligodendrocytes
- Clinical:
- Marked hypotonia with poor head control 1st few wks of life
- Macrocephaly 2° to ↑ skull growth, psychomotor delay, spasitcity,
intellectual failure, cortical blindness and seizures with death by 3
years.
|
|
38
|
- MR Imaging features:
- Subcortical WM affected early and is most severe in the cerebral and
cerebellar hemispheres
- Central WM structures (internl capsule, corpus callosum,
periventricular rim WM are preseved)
- Progressive ↑ T2 and ↓ T1 in the cerebral WM centripetal
and confluent in distribution
|
|
39
|
|
|
40
|
- Inheritance pattern:
- Gene mutation for glial fibrillary acidic protiens (GFAP) with
accumulation in the cytoplasm resulting in cellular dysfunction
- Diagnosis strongly suggested with combination of macrocephaly, with
clinical and imaging findings along with GFAP gene confirmation
- 3 forms:
|
|
41
|
- Clinical:
- Macrocephaly, early onset clinical findings and imaging studies
strongly suggest diagnosis, however, biopsy remains the definitive
diagnostic tool
- Accumulation of Rosenthal fibers – hallmark
- Neonatal form is most severe, rapidly progressive, onset within
1st month of life, death within 2 yrs of life
- Juvenile type, symptoms occur between 7 and 14 yrs, progressive bulbar
signs and spasticity
- Adult form, similar clinical presentation to multiple sclerosis
|
|
42
|
- MR Features:
- ↑ T1 & ↓ T2 periventricular and subcortical WM in
frontal lobes, external and extreme capsules
- ↓ T1 & ↑T2 in caudate head, basal ganglia and
hypothalamus
- Marked T1 hyperintensity periatrial ependymal lining
- Occipital lobes are spared
|
|
43
|
- Inheritance pattern:
- Classic form : X-linked recessive
- Connatal form : X-linked or autosomal recessive
- Enzyme defect:
- Accumulation of proteolipid protein 1 in the endoplasmic reticulum
resulting in partly formed myelin molecules
- Clinical:
- Abnormal eye movements, nystagmus, extrapyramidal hyperkinesia,
spasticity, seizures
- Death occurs in adolescence to early adulthood in the classic variety
and in early childhood for connatal form
|
|
44
|
- MR imaging features
- ↑ T2 signal of all unmyelinated white matter extending to the
subcortical U fibers, with corresponding ↓ T1 signal changes
- Some sparing of myelin in parts of the brainstem
- Progressive white matter atrophy
|
|
45
|
|
|
46
|
|
|
47
|
- Etiology:
- Presumed autoimmune
- Idiopathic
- Facts:
- First described by Charcot in 1868, MS is the most common demyelinating
disease encountered in clinical practice as well as in imaging.
- Peak age : 30 years with a female predominance
- (Can also occur in children and adolescents and those over 50 years)
|
|
48
|
- Clinical:
- MS is a multiphasic disease with clinical symptoms presenting in 2 or
more episodes spaced at least 1 month apart, according to the
Schumacher criteria.
- Clinical presentation in childhood can present subtly as school-related
problems and paresthesias, to diffuse encephalopathy with cerebral
edema, meningismus and impaired consciousness.
- MR imaging can supplement the diagnosis by documenting the
dissemination of lesions in space and time.
|
|
49
|
- MR Imaging
- Imaging findings in children are not significantly different from those
in adults.
- Sharply marginated lesions showing ↓ T1 and ↑ T2 signal in
the periventricular white matter, including the corpus callosum.
- Variable enhancement depending on acuity of the lesion – new lesions
enhance for an average of 3 weeks.
- Spinal cord lesions with associated cord swelling
- Plaques can show restricted diffusion (fig d, e & f)
- Tumefactive lesions are more common in children (fig c)
|
|
50
|
- MR Imaging:
- Recommended diagnostic criteria for MS in children:
(at least 3 of the following)
- One enhancing lesion or nine T2 bright lesions
- At least one infratentorial lesion (fig c)
- At least one juxtacortical lesion
- At least 3 periventricular lesions (fig b)
- One spinal cord lesion may be substituted for one brain lesion
- Enhancement is characteristically limited to one side of the lesion,
along the demyelinating edge
(fig d)
|
|
51
|
- A variant of MS, NMO is a syndrome consisting of optic neuritis, often
with bilateral total blindness, in combination with transverse myelitis,
usually thoracic in location.
- The optic neuritis and transverse myelitis can occur simultaneously or
separated by a brief interval of
several days to several weeks.
- Age range: 5 to 65 years (but rare over 50 years)
- No gender predilection
- More common in the Asian population, where the overall incidence of MS
is low
- Prognosis is poor
- Until recently 15-20% of patients died in the acute stage due to
ascending disease with respiratory arrest
- Now complete or near complete recovery occurs in roughly 35%
|
|
52
|
|
|
53
|
|
|
54
|
- Etiology:
- Thought to be an autoimmune response to a CNS antigen triggered by
viral infections
- Facts:
- An inflammatory/demyelinating process seen more frequently in children,
but affects all age groups
- Typically a monophasic self-limited illness within weeks after:
- Non-specific respiratory illness
- Specific viral illness (measles, mumps, rubella, chickenpox, tetanus,
flu)
- Vaccinations (rabies, diptheria, smallpox, tetanus, typhoid)
- Clinical:
- fever/headache/mental status changes/meningeal signs/ focal deficits
(usually resolve ~ 1 month).
|
|
55
|
- MR Features:
- Virtually identical to MS
(mass-like with no mass effect)
- T2 bright lesions:
- Supratentorial white matter (fig a)
- Brainstem (fig b)
- Cerebellum
- Deep white matter (fig c)
- Optic Neuritis
- Spinal cord involvement
- Lesions can enhance and show restricted diffusion
(fig d arrow)
|
|
56
|
- Etiology:
- A chronic measles virus infection which causes apoptosis of neurons,
oligodendrocytes & lymphocytes.
- Although a rare disorder, it is the commonest of the chronic viral
infections to affect children.
- Facts:
- Age range: 4 – 25 years; peak at
9 years; rare in adults
- Children who acquire measles under 1 year of age are more likely to
develop SSPE.
- Clinical:
- Can be quite variable and range from 3 months to 7 years, usually with
4 discernable stages:
- Stage 1: insidious intellectual & behavioral deterioration,
slurred speech, vision changes
- Stage 2: Myoclonia of all somatic muscles, convulsions,
choreoathetosis, tremor & spasticity
- Stage 3: Severe dementia, frequent extrapyramidal dysfunction,
myoclonia diminishes
- Stage 4: Child is in a vegetative state characterized by mutism and
decerebrate or decorticate posture
|
|
57
|
- MR Features:
- Abnormal signal can be seen:
- Focal:
- Basal Ganglia
- Lateral geniculate bodies
- Diffuse:
- Subcortical white matter (WM)
- Deep & periventricular WM
- The overlying cortex is often affected (fig a)
- Bilateral striatal lesions, brain stem lesion, and cerebellar peduncle
lesions are also seen.
- End-stage disease shows diffuse atrophy
|
|
58
|
- Etiology:
- PML is a rare demyelinating infection of the CNS by the JC polyomavirus
virus -- a papovavirus
- Facts:
- Predominantly occurs in immunodeficient patients, and in recent years
has been seen most commonly in the context of AIDS.
Also seen in association with:
- Lymphoma/ SLE/ renal transplantation/ Multiple Myeloma/ Sarcoid/ TB/
Whipple disease
- Predominantly seen in adults, but has been described in children with
similar imaging findings.
|
|
59
|
- Clinical:
- Typical early presentation includes cognitive impairment, sometimes
with personality changes.
- Monoparesis, hemparesis, dysarthria, ataxia, sensory impairments and
visual loss ensue.
- Quadriparesis, severe dementia and coma are seen in advanced stages of
the disease.
- Once the disease appears it typically progresses until the patient
dies.
|
|
60
|
- MR Features:
- Lesion with ↑ T2 signal can be found anywhere in the cerebral or
cerebellar WM and the brainstem
- Most commonly involves the
frontal and parieto-occipital subcortical WM; but can involve
basal ganglia and thalami (fig a)
- Subcortical lesions form a scalloped appearance where they border the
overlying gray matter.
- Confluence of multiple lesions give rise to the appearance of wide
spread white matter disease
- Enhancement is seen in a minority of cases
|
|
61
|
- An acute encephalopathy with thalamotegmental involvement
- Most likely immune-mediated or metabolic
- Influenza A and B viruses and human herpes virus have been implicated
- Clinical:
- Infants between 6 to 18 months
- History of mild antecendent illness (90%) ~ 3 days followed by acute
onset of convulsions, impaired conscoiousness, vomiting, coma in
24 hrs
- Biochemical analysis shows
- ↑ aspartate amino-transferase (82%)
- ↑ alanine aminotransferase (70%)
- ↑ lactate dehydrogenase (77%)
|
|
62
|
- MR imaging features
- Bilateral thalamic involvement with ↑ T2 and ↓ T1 signal
- Confluent lesions involving lateral putamina and external and extreme
capsules
- These lesions become hemorrhagic and cavitate centrally
- Calcifications can be seen in the basal ganglia
|
|
63
|
|
|
64
|
- Hypertensive episodes lead to transient clinical symptoms such as
headache, nausea, vomiting, altered mentation and seizures.
- The MR findings can be associated with the following disease entities:
- Pre-eclampsia/ Eclampsia
- Renal insufficiency
- Hemolytic-uremic syndrome
- Thrombotic thrombocytopenic purpura
- Patients undergoing chemotherapy/ immunosuppressive therapy and bone
marrow or solid organ transplantation
- Presumed etiologies:
- Immunological maternal reaction (in eclampsia)
- Dietary factors
- Genetic factors
|
|
65
|
- MR Features:
- ↑ T2 and ↓ T1 signal predominantly affecting the
parieto-occipital regions symmetrically
- Involves white matter as well as cortex
- May solely affect the thalami, frontal border zones, midbrain, pons or
cerebellum
- Initial period may have associated mass effect and hydrocephalus
- Some lesions may progress to infarction and DWI must be utilized
- With treatment lesions disappear completely or nearly completely
|
|
66
|
- Abnormalities in the white matter 2° chemotherapy agents
- Most common offending agents
- Methotrexate, Cisplatin, Arabinosylcytosine, Carmustine, Thiopeta
- WM abnormalities may be transient or permanent,
with or without associated clinical abnormalities
- Clinical:
- Neurologic symptoms occur with acute injury
|
|
67
|
- MR imaging features
- Symmetric ↑ T2, ↓ T1 abnormalities
- Central and periventricular WM, can be wide spread and diffuse
- Relative sparing of U-fibers
- Diffusion imaging shows reduced diffusion in affected areas (figs c
& d)
|
|
68
|
- Pediatric leukoencephalopathies comprise a broad group of disease
entities many of which may have non-specific MR imaging characteristics
which overlap one another
- Certain imaging findings, however, are characteristic and were
highlighted in this presentation
- We’ve found that a systematic approach, using a well-described
classification system, along with imaging, clinical and biochemical
data, helps to narrow the differential
|
|
69
|
- Van der Knaap MS, Jaap V. Magnetic Resonance of Myelination and Myelin
Disorders. Third edition. Springer-Verlag Berlin Heidelberg, 2005.
- Barkovich JA. Pediatric Neuroimaging. Fourth edition. Lippincott
Williams & Wilkins, 2005.
- Cheon JE et al. Leukodystrophy in Children: A Pictorial Review of MR
Imaging Features. Radiographics 2002;22:461-476.
- Suzuki K, Armao D, Stone JA, Mukherji SK. Demyelinating Diseases,
Leukodystrophies, and Other Myelin Disorders. Neuroimaging Clin N Am 2001;11(1):15-35.
- Osborn. Diagnostic Imaging Brain. First Edition. Amirsys Inc 2004.
|